Cerenome, Inc. (CNSY) vs Senti Biosciences, Inc. (SNTI)
A side-by-side comparison of Cerenome, Inc. and Senti Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CNSY
Cerenome, Inc.
$1.62HealthcareDelayed quote: Oct 6, 2026, 3:44 PM EDT
SNTI
Senti Biosciences, Inc.
$0.32HealthcareDelayed quote: Oct 6, 2026, 3:50 PM EDT
Total return — CNSY vs SNTI
growth of $100 · dividends reinvested · last 1yCNSY -61.5% (-61.5%/yr)SNTI -67.7% (-67.7%/yr)CNSY compounded faster over this window
CNSY SNTI
CNSY vs SNTI: by the numbers
- •CNSY is the larger company ($11M vs $10M market cap).
- •Both run net losses; CNSY's is the smaller (-620.70% vs -90116.36% net margin).
Metrics side by side
Valuation
| Metric | CNSY | SNTI |
|---|---|---|
| P/S ratio | 2.65 | 181.26 |
| P/B ratio | 2.04 | N/A |
Profitability
| Metric | CNSY | SNTI |
|---|---|---|
| Gross margin | 89.58% | -16431.82% |
| Operating margin | -293.46% | -289668.18% |
| Net margin | -620.70% | -90116.36% |
| ROE | -477.54% | N/A |
| ROIC | -479.39% | -227.67% |
Growth (annualized)
| Metric | CNSY | SNTI |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -43.85% |
| Total return CAGR (5Y) | N/A | -67.75% |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.